Christopher M. Smith - Aug 15, 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
Aug 15, 2024
Transactions value $
$0
Form type
4
Date filed
8/19/2024, 04:19 PM
Previous filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -33.1K -4.88% $0.00 646K Aug 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 694K Aug 15, 2024 Common Stock 694K $12.62 Direct F2
holding NEO Stock Option (Right to Buy) 270K Aug 15, 2024 Common Stock 270K $19.65 Direct F3
holding NEO Restricted Stock Unit 96.1K Aug 15, 2024 Common Stock 96.1K $0.00 Direct F4, F5
holding NEO Performance Stock Unit 144K Aug 15, 2024 Common Stock 144K $0.00 Direct F5, F6
holding NEO Stock Option (Right to Buy) 288K Aug 15, 2024 Common Stock 288K $16.45 Direct F7
holding NEO Restricted Stock Unit 172K Aug 15, 2024 Common Stock 172K $0.00 Direct F5, F8
holding NEO Performance Stock Unit 172K Aug 15, 2024 Common Stock 172K $0.00 Direct F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 15, 2024 vesting of restricted stock.
F2 On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4 On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5 Once vested, the shares of common stock are not subject to expiration.
F6 On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F7 On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F8 On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F9 On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.